LAS VEGAS—Whoop gained traction as a performance wearable used by elite athletes, professional teams and Olympians to track physiological strain and sleep.

It has been revealed that the company has evolved into a broader clinical and digital health platform that layers medical-grade hardware, blood diagnostics, electronic health record (EHR) syncing, and physician care on top of its continuous biometric tracking. The company's FDA-cleared ECG detects signs of atrial fibrillation and allows members to share results with their healthcare provider.

According to recent reports, whoop is a screenless, wrist-worn device that measures strain, recovery and sleep 24/7, paired with Whoop Coach, an AI-powered, in-app health and fitness assistant. The organization expanded its Advanced Labs testing—combining Quest blood testing, clinician reviews and AI insights—to non-members, alongside integrating Grail's multi-cancer early detection test. Whoop partners with health platform HealthEx to let people connect their medical records directly to the Whoop app, combining medical history with biometric data. A feature rolled out earlier this year lets Whoop members directly connect with clinicians through the app, including live, on-demand video consultations.

The company has raised over $900 million to date, including a $575 million series G round in March, pushing its valuation to $10 billion. Whoop told Bloomberg it aims to hire 600 people this year, a roughly 75% boost to its headcount, as it works to further integrate AI into its health and wellness monitoring tools and to expand internationally. The company is on track for an initial public offering in 18 months, executives told Bloomberg in August.

Sources indicate that the firm is positioning itself as a continuous health monitor that goes beyond fitness tracking. The device's 24/7 physiological data can function almost like an ongoing health check, becoming a bridge between everyday health and medical care, Will Ahmed, founder and CEO of Whoop, said during an on-stage interview at HLTH on Tuesday.

Ahmed argued that the conventional annual medical physical is "frozen in time.".

It has been revealed that "The reality is wearing a continuous health monitor like Whoop that should be a 24/7 annual checkup. That's how it should function from a data standpoint," he stated during a fireside chat with Michael Phelps, U.S. former competitive swimmer, who is the most decorated Olympian in history with 23 gold medals, and also a Whoop customer since 2015.

"Then there will be alerts when something is really wrong, and particularly as we combine these different data sources together, again, 24/7 physiological data, blood tests, medical records, how you're feeling and contextual cues. When we have all this information in one place, and now we've got 3.5 million members, about to be 4 million members, it's just amazing the insights that you can pull together from that. And so you can start to predict that someone may need to get a cancer screening, or may actually have a real heart problem," he stated.

In a recent development, whoop can pull together biometric data, labs, medical records and information to establish a baseline for an individual, recognize meaningful changes and recommend an action. By combining continuous monitoring with information such as blood tests, the manufacturer hopes to help consumers piece together health signals and determine when they may need care, Ahmed noted.

For Phelps, Whoop has shifted from being about maximizing elite athletic performance to helping him manage his health, energy and recovery around everyday life and longevity, he told the audience.

"For me, for 20-plus years, I've been trying to chase time, and now I'm just trying to be the healthiest person that I can be," Phelps remarked. "For me, the data that I get every single day, if my body isn't 100% or I'm not full go, then I take a step back and I tone down my workout. When I'm talking to my trainer, I'm taking it down a little bit, so I have enough energy and I have what I need to be a good dad, to be a good husband, to be a good worker, hard worker, whatever it is, just to be a good person.".

In a recent development, whoop sees opportunities to turn deviations from an individual's baseline into actionable signals. During the COVID-19 pandemic, Phelps said his Whoop device signaled that his temperature, respiratory rate and HRV changed, but he noted that the real benefit was that Whoop knew what normal looked like for him.

Using biometric data to recognize signals in a person's health can have broader implications, Ahmed noted, citing examples where members identified potentially serious health problems after noticing significant changes in their physiological data.

"We're just starting to see all of these different maps presenting themselves, and it's very empowering. We're excited about the role that we can play with the broader health ecosystem," Ahmed mentioned.

Ahmed stated Whoop's high user engagement and continuous monitoring can fill gaps between doctors' visits and provide clinically relevant information to care teams.

"I do believe that technology like Whoop can make the whole system much more efficient and also make a doctor's life easier if we do our jobs properly, which is again to say, how do you take all this information that's being collected about a patient or a consumer and how do you simplify it to the one, two, or three questions that a doctor might actually want to know the answer to before you show up to their office?" he said.

Ahmed sees the AI coach evolving into a personal health companion sitting on top of a longitudinal health record.

"That's another area that we're really excited about, where this idea that you can have a conversation with Whoop or what feels like this entity that sits on top of your data, and all of a sudden you feel like you have a health companion, and yes, you've got 24/7 physiological data from sensors, but you can also now have your medical records. You can also now have your blood tests. There are all sorts of conversational cues. 'How are you feeling today?' 'Did you drink alcohol last night?' Were you traveling?' You put all that information together, all that data in one place, and the insights are quite profound," he said.

Partnerships with other digital health companies and acquisitions help Whoop broaden the platform, he noted.

"We like to think about it from the consumer's vantage point first, which is to say, if you're an individual, if you're a consumer, what is data that you want on your body or you need on your body, and that may be data that's being collected somewhere else, in which case, we feel like there could be an opportunity for a partnership," Ahmed said, adding, "We're also comfortable now acquiring technology and acquiring different innovations, which has become more of a muscle that we've built over the last 12 months.".

Whoop believes its biggest strategic advantage is the consumer relationship.

Members open the app roughly eight times a day and wear the device nearly 23 hours a day.

"There are so many of us who have been in health tech where we would die for that kind of engagement, and I think that's something we're always striving for because we're an industry that was never built with the consumer in the center," mentioned Lynne O'Keefe, founder and manager partner of Define Ventures, who moderated the on-stage interview.

The company is strategically expanding into an older, more medical population. Whoop is a participant in the Centers for Medicare and Medicaid Services' ACCESS model. Ahmed said members 65 and older are actually Whoop's most highly engaged demographic, challenging the assumption that consumer health technology primarily appeals to younger people.

"It's clearly a population that cares a lot about their health. They want to focus on what's going on with their blood pressure, their ECG, or whether they need to send data to their doctors," he said.

Ahmed framed CMS' ACCESS model as a move from consumers simply paying for a wearable toward government reimbursement tied to measurable health outcomes, such as improvements in blood pressure or weight.

"I think as a model of innovation for a government and its citizens, it's pretty interesting because it incentivizes companies to actually create technology or programs that are making people healthier. It should change the cost curve because you're paying if that outcome is delivered, and then to the consumer, you're both hopefully being healthier and not paying for a product that otherwise would have had to," he noted.

Whoop also positions itself as a platform that can wrap around drugs and other healthcare interventions. The manufacturer announced this week a partnership with Novo Nordisk as part of the pharma company's redesign of its direct-to-consumer NovoCare program. Novo Nordisk relaunched its NovoCare direct-to-consumer program. Patients taking a GLP-1 can integrate wearable data from Whoop as part of their program.

Whoop can function as a potential companion for GLP-1 owners, monitoring exercise, sleep, resting heart rate, HRV and other signals while helping users preserve health and fitness during treatment, Ahmed said.

Sources indicate that when asked about the future vision for Whoop, he remarked, "I think in simple terms, it's our responsibility to build technology that either makes you healthier or one day saves your life. You're going to have all of this health data on your body. I think organizing that information in one place, alongside 24/7 wearable data, and alongside a powerful AI that can sit on top of that data and go off on your behalf and take actions and schedule appointments with the doctor, or go speak to your doctor on your behalf, or alert you when something's wrong," he said.

He added, "God forbid this day comes, but you should wake up and be told from Whoop you need to go to the doctor in the next 30 minutes, and it's been scheduled, and you show up, and all of a sudden you find out that you're having a heart attack, or you're having some serious life event. To me, that feels like an inevitable future, and I do predict that a large percentage of humanity in the future will be wearing a continuous health monitor.".

→ Read original article